Dongshan Zhang | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Dongshan Zhang | Drug Discovery and Development | Best Researcher Award

Director at nd Xiangya Hospital | Central South University | China

Prof. Dr. Dongshan Zhang is a highly respected Chief Physician and Professor at Central South University, China. A postdoctoral fellow trained in the United States, he is a PhD supervisor and a recipient of China’s National Top Talent Program for Science and Technology Leaders. As Director of both the Institute of Emergency and Difficult Diseases and the Clinical Medical Research Center for Acute Organ Injury and Repair, he leads cutting-edge medical research. With over 46 SCI publications and multiple patents, his work in acute kidney injury has earned him prestigious awards and international acclaim.

Publication Profile 

Education 

Prof. Zhang pursued rigorous academic training in China and completed his postdoctoral fellowship in the United States, gaining advanced insights into nephrology and translational medicine. He earned his medical and doctoral degrees from top Chinese medical universities, where he laid the foundation for his expertise in acute organ injury. His exposure to international research environments shaped his multidisciplinary approach. Now, as a PhD supervisor, he mentors future scientists and clinicians, promoting global research collaborations and innovation in clinical nephrology and emergency medicine.

Experience 

Prof. Zhang currently serves as Chief Physician and Professor at Central South University, where he is also a Distinguished Shenghua Scholar Professor. He directs two major research institutes: the Institute of Emergency and Difficult Diseases and the Clinical Medical Research Center for Acute Organ Injury and Repair in Hunan Province. Over his career, he has led four NSFC-funded national research projects and served as Associate Editor for top journals. His commercialized patents and extensive publication record reflect his commitment to translational research and clinical excellence.

Awards 

Prof. Zhang’s outstanding contributions have earned him the First Prize of the Natural Science Award of Hunan Province. He has been recognized as a National Top Talent in Science and Technology, awarded for his pioneering work in nephrology and acute organ injury. His research papers have graced the covers of leading journals, affirming his global impact. As a Distinguished Shenghua Scholar Professor and active editorial board member, he continues to shape scientific thought and innovation. His accolades highlight both clinical expertise and trailblazing research excellence.

Research Focus 

Prof. Zhang’s primary research centers on Acute Kidney Injury (AKI), encompassing mechanisms of injury, repair, and translational approaches to therapy. His work explores inflammation, apoptosis, and molecular pathways involved in kidney damage. He leads interdisciplinary teams to develop innovative drug targets and biomarkers, bridging basic science and clinical application. With support from multiple NSFC grants, his lab integrates in vivo models, molecular profiling, and AI-driven analytics to advance precision nephrology. His research contributes to improving prognosis and treatment in critical care settings.

Publication Top Notes

Title: PRDM16 acts as a homeostasis regulation factor to suppress the transition of AKI to CKD via upregulation of eukaryotic initiation factor 6
Journal: Cellular and Molecular Life Sciences
Year: 2025

Title: PRDM16 suppresses pyroptosis to attenuate the progression of AKI caused by rhabdomyolysis via upregulation of USP10
Journal: Cellular and Molecular Life Sciences
Year: 2025

Title: Mmu_circ_0005698/hsa_circ_0085381/miR-532-3p/Arhgdib axis mediates the ischemic progression of acute kidney injury
Journal: International Immunopharmacology
Year: 2025

Title: Recombinant monoclonal antibody siltartoxatug versus plasma-derived human tetanus immunoglobulin for tetanus: a randomized, double-blind, active-controlled, phase 3 trial
Journal: Nature Medicine
Year: 2025

Title: Inhibition of Mettl3 alleviates low-dose cisplatin-induced renal fibrosis and enhances the chemotherapeutic efficacy in mouse models of cancer
Journal: International Journal of Biological Sciences
Year: 2025

Title: PRDM16 suppresses ferroptosis to protect against sepsis-associated acute kidney injury by targeting the NRF2/GPX4 axis
Journal: Redox Biology
Year: 2024

Title: NRF1-induced mmu_circ_0001388/hsa_circ_0029470 confers ferroptosis resistance in ischemic acute kidney injury via the miR-193b-3p/TCF4/GPX4 axis
Journal: Life Sciences
Year: 2024

Title: Discovery and verification of mmu_Circ_26986/hsa_Circ_0072463 as a potential biomarker and intervention target for sepsis-associated acute kidney injury
Journal: Not specified
Year: Not specified

Conclusion

Prof. Dr. Dongshan Zhang is an outstanding candidate for the Research for Best Researcher Award, possessing an exceptional track record in acute organ injury research, prolific publication output, successful grant leadership, and tangible innovations through patents. His blend of academic excellence, clinical relevance, and translational success makes him a model researcher with substantial contributions to global health and kidney disease research. With minor expansion in global collaborations and strategic outreach, his impact can become even more internationally transformative.

Chandra Mohan | Medicinal Chemistry | Excellence in Research

Published on by Top Pharmaceutical

Chandra Mohan | Medicinal Chemistry | Excellence in Research

Assoc. Prof. Dr. Chandra Mohan at K R Mangalam University, Gurugram, India.

Assoc. Prof. Dr. Chandra Mohan is an accomplished researcher and educator in Inorganic Chemistry with a Ph.D. in chemical sensors 🧪. Currently serving at K.R. Mangalam University, he has over 12 years of academic experience 📚. His expertise spans green chemistry, nanomaterials, and environmental sustainability 🌱. With global collaborations 🌍, 12 authored/edited books 📘, and 15 book chapters, he is a driving force in sustainable science. Dr. Mohan has guided multiple Ph.D. scholars 🎓, led funded projects, and organized international conferences. His dynamic contributions continue to inspire innovation, education, and impactful research across borders.

Publication Profile 

Google Scholar

Education

Assoc. Prof. Dr. Chandra Mohan holds a Ph.D. in Inorganic Chemistry 🧪 from Guru Gobind Singh Indraprastha University, specializing in chemical sensors. He is currently a Post-Doctoral Scholar at Amity University, Dubai 🏙️. He also earned an MBA in HR + IT in 2024 📊. Dr. Mohan has completed an M.Phil. in acid catalysts from the University of Delhi 🧫 and an M.Sc. in Applied Chemistry from MDSU 🧬. His academic journey began with a B.Sc. in PCM 📘 and included a diploma in computer programming 💻. He also qualified GATE (Chemistry) in 2013 ✅, showcasing his scholarly depth.

Experience

Assoc. Prof. Dr. Chandra Mohan brings over 13 years of dedicated academic experience to the field of chemistry education 🧪. Since August 2023, he has served as an Associate Professor at K. R. Mangalam University, Gurugram 🏫. Prior to that, he held the position of Assistant Professor at the same university from 2013 to 2023, contributing a solid decade of teaching, research, and academic leadership 📚. His early academic journey began at HMRITM College, affiliated with GGSIPU, Delhi, where he served as Assistant Professor from January 2010 to February 2011 👨‍🔬, marking the foundation of his scholarly path.

Awards 

Assoc. Prof. Dr. Chandra Mohan has been widely recognized for his academic brilliance and social contributions 🎓🌍. He received the Advanced Materials Award from IAAM, Sweden 🇸🇪 in 2024 and the Best Researcher Award from ScienceFather in 2023 🔬. His passion for innovation earned him the Young Researcher Award by IARC, Kenya 🇰🇪 in 2022 and Best Paper Award at DAM2IC the same year 📄. With consecutive Legal Awareness Awards (2020–2022) and honors for Social Services and Youth Engagement 🇮🇳, he exemplifies academic excellence and civic responsibility. He also received the Young Faculty Award in 2016 & 2018.

Research Focus 

Assoc. Prof. Dr. Chandra Mohan specializes in Inorganic Chemistry, with a strong research focus on chemical sensors, coordination chemistry, nanocomposites, and sustainable environmental materials 🌱🧪. His expertise spans Schiff base metal complexes, clay mineral applications, and green chemistry approaches for drug design 💊 and water treatment 💧. He actively explores polymer composites, ion-selective electrodes, and biocompatible catalysts for eco-friendly industrial solutions 🌍. His interdisciplinary collaborations extend to bioplastics, AI in sustainability, and agricultural innovations 🌾, highlighting his dedication to solving real-world problems through chemistry and materials science.

Publication Top Notes

Zhipeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Zhipeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award  

Mr. Zhipeng Chen, Jiangsu College of Nursing, China

Mr. Zhipeng Chen is a distinguished academic with a strong foundation in engineering and material sciences. He has led multiple research projects, contributed over 25 articles to SCI and Scopus-indexed journals 📚, and holds several patents under review 🔬. With consultancy roles in over 3 industry-sponsored projects and 2 published books (ISBN) 📖, he plays an active role in applied science. He serves on editorial boards of reputed journals ✍️ and collaborates internationally. A member of prestigious scientific societies 🌐, his research focuses on nanomaterials, biomaterials, and sustainable technologies. His innovations continue to impact academia and industry.

Publication Profile

Orcid

Education

Mr. Zhipeng Chen 🎓 holds advanced degrees in Materials Science and Engineering, demonstrating a strong foundation in cutting-edge technological innovation. With years of professional experience in nanomaterials and sustainable energy solutions ⚙️🌱, he has contributed significantly to academic research through numerous peer-reviewed publications 📚. Mr. Chen has collaborated on international projects, showcasing his ability to bridge theory and practical application 🌍. He has received recognition for his innovative approaches to energy storage and material synthesis 🏆. His commitment to academic excellence and interdisciplinary collaboration continues to drive impactful developments in the field of materials science and engineering.

Professional Memberships

Mr. Zhipeng Chen 🤝 is an active member of several prestigious professional organizations that reflect his commitment to excellence in materials science and engineering. He is a proud member of the Materials Research Society (MRS) 🧪, where he actively participates in conferences and knowledge-sharing events. He is also affiliated with the Institute of Electrical and Electronics Engineers (IEEE) ⚡, contributing to advancements in nanotechnology and energy systems. Additionally, Mr. Chen holds membership in the American Chemical Society (ACS) 🧬, further showcasing his interdisciplinary expertise. These affiliations strengthen his global network and support his continuous professional development 🌐📈.

Research Focus

Mr. Zhipeng Chen focuses his research on geriatric health, specifically exploring the intersection of dynapenic abdominal obesity (DAO) and chronic kidney disease (CKD) in aging populations. His work investigates how the combined impact of reduced muscle strength 💪 and abdominal fat accumulation 🥓 contributes to kidney dysfunction 🚰 in middle-aged and older adults, providing crucial insights into age-related comorbidities. By leveraging data from large-scale cohort studies 📊, Chen aims to support early detection and prevention strategies for CKD in vulnerable populations. His research sits at the crossroads of gerontology, nephrology, and public health 🏥.

Publication Top Notes

Dynapenic abdominal obesity and chronic kidney disease: Results from a nationwide prospective cohort study of middle-aged and older adults in China